ALZpath, Alamar Biosciences Expand Agreement for Alzheimer’s Blood Diagnostics
ALZpath and Alamar Biosciences have expanded their strategic agreement to include clinical diagnostics for Alzheimer’s disease. The broadened…
Blood Test Boosts Alzheimer’s Diagnosis Accuracy in Primary Care: AAIC 2026 Study
Blood test results allow primary care physicians to diagnose Alzheimer’s disease with nearly the same accuracy as specialists,…
NIH Study: Blood Test Using Circular RNAs Predicts Alzheimer’s Progression
Elevated levels of specific circular RNAs in the blood nearly tripled the risk of developing Alzheimer’s disease symptoms,…